
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
96,60 | 96,65 | 13:32 | |
96,58 | 96,66 | 13:31 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Bernstein cuts Regeneron stock price target to $979, maintains Outperform | ||
Di | Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 52-Week Low on Analyst Downgrade | ||
Di | Japan's MHLW authorises Regeneron and Sanofi's Dupixent for COPD | ||
So | Regeneron Pharmaceuticals, Inc. (REGN): Among Blue Chip Stocks to Invest in at 52-Week Lows | ||
28.03. | Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 12-Month Low - What's Next? |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
10:46 | FDA awards ODD status to Sanofi's rilzabrutinib for two rare conditions | ||
Do | Sanofi Winthrop Industrie: Sanofi: Information concerning the total number of voting rights and shares - February 2025 | ||
Do | Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday? | ||
Do | Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday | ||
Do | BERNSTEIN RESEARCH stuft SANOFI auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Sanofi auf "Outperform" mit einem Kursziel von 114 Euro belassen. Analyst Florent Cespedes wertete in einer... ► Artikel lesen |
Unternehmen / Aktien | Kurs | % |
---|---|---|
REGENERON PHARMACEUTICALS INC | 541,60 | -2,24 % |
SANOFI SA | 97,06 | -2,65 % |